ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $423,293 | +13.1% | 861 | -10.3% | 0.10% | +16.1% |
| Q2 2023 | $374,141 | -5.4% | 960 | -9.6% | 0.09% | -8.4% |
| Q1 2023 | $395,680 | -4.3% | 1,062 | -2.7% | 0.10% | -6.9% |
| Q4 2022 | $413,304 | -4.5% | 1,091 | -11.1% | 0.10% | -6.4% |
| Q3 2022 | $433,000 | -6.9% | 1,227 | +0.1% | 0.11% | -0.9% |
| Q2 2022 | $465,000 | -8.5% | 1,226 | -23.9% | 0.11% | +17.0% |
| Q1 2022 | $508,000 | -8.8% | 1,611 | +1.3% | 0.09% | 0.0% |
| Q4 2021 | $557,000 | +50.9% | 1,590 | +30.2% | 0.09% | +42.4% |
| Q3 2021 | $369,000 | +12.5% | 1,221 | +12.1% | 0.07% | +8.2% |
| Q2 2021 | $328,000 | – | 1,089 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |